Palvella Therapeutics (PVLA) Receivables - Net (2016 - 2024)
Historic Receivables - Net for Palvella Therapeutics (PVLA) over the last 11 years, with Q3 2024 value amounting to $500000.0.
- Palvella Therapeutics' Receivables - Net fell 5215.31% to $500000.0 in Q3 2024 from the same period last year, while for Sep 2024 it was $500000.0, marking a year-over-year decrease of 5215.31%. This contributed to the annual value of $5.8 million for FY2022, which is 6582.35% down from last year.
- Per Palvella Therapeutics' latest filing, its Receivables - Net stood at $500000.0 for Q3 2024, which was down 5215.31% from $1.5 million recorded in Q2 2024.
- In the past 5 years, Palvella Therapeutics' Receivables - Net registered a high of $17.0 million during Q2 2021, and its lowest value of $500000.0 during Q3 2024.
- Moreover, its 5-year median value for Receivables - Net was $1.8 million (2020), whereas its average is $4.5 million.
- Its Receivables - Net has fluctuated over the past 5 years, first soared by 12574.73% in 2021, then plummeted by 9256.47% in 2022.
- Quarter analysis of 5 years shows Palvella Therapeutics' Receivables - Net stood at $1.7 million in 2020, then soared by 94.2% to $3.3 million in 2021, then soared by 75.37% to $5.8 million in 2022, then tumbled by 82.01% to $1.0 million in 2023, then crashed by 52.15% to $500000.0 in 2024.
- Its Receivables - Net stands at $500000.0 for Q3 2024, versus $1.5 million for Q2 2024 and $1.8 million for Q1 2024.